Verastem Inc (VSTM)
2.55
-0.08 -3.04%
NASDAQ
Sep 15, 16:00
2.555
0.00 0.00%
After-Hours: 16:58
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 80.66M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -0.23 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -38.66M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -3.38K% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0.00% |
| Price and Valuation | |
| Market Cap | 460.93M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 5.401 |
| PE Ratio | -- |
| Price to Book Value | 5.226 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 0.2304 |
| Free Cash Flow (Quarterly) | -13.42M |
| Return on Equity | Upgrade |
View All VSTM News
News
-
WireHeadlineTime (ET)
-
Yahoo09/10 12:54
-
Yahoo09/07 07:00
-
Yahoo08/05 09:06
-
MT Newswires08/03 12:46
-
SA Breaking News08/03 11:03
-
MT Newswires08/02 16:06
-
MT Newswires08/02 16:06
-
Yahoo08/02 16:05
-
Yahoo07/27 07:00
-
MT Newswires07/20 11:31
-
Yahoo07/19 16:01
-
MT Newswires07/19 09:14
-
MT Newswires07/19 07:44
-
Yahoo07/19 07:00
-
Yahoo07/06 07:00
-
Yahoo06/30 07:53
-
Yahoo06/24 07:00
-
Yahoo06/21 10:00
-
SA Breaking News05/26 09:46
-
PR Newswire05/25 08:30
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 11/09/2021 | Earnings Results | Q3 2021 Earnings Results |
| 08/02/2021 | Earnings Results | Q2 2021 Earnings Results |
| 05/18/2021 09:00 EST | AGM | 2021 Annual General Meeting |
| 05/11/2021 | Earnings Results | Q1 2021 Earnings Results |
| 03/18/2021 | Earnings Results | Q4 2020 Earnings Results |
| 11/09/2020 | Earnings Results | Q3 2020 Earnings Results |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- Description: Verastem Inc is a part of the healthcare sector. It is a commercial-stage company focused on discovering and developing drugs to aid patients suffering from cancer. The company's first commercial product, COPIKTRA (duvelisib) is indicated for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma after at least two prior therapies and relapsed or refractory follicular lymphoma after at least two prior systemic therapies. The company's product pipeline candidate, defactinib, is a focal adhesion kinase inhibitor in development for the treatment of cancers where there are limited treatment options, including lung, ovarian, lymphoma, pancreatic, and other advanced cancers.
- URL: https://www.verastem.com
- Investor Relations URL: https://investor.verastem.com/events/
- HQ State/Province: Massachusetts
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Growth
- Next Earnings Release: Nov. 09, 2021
- Last Earnings Release: Aug. 02, 2021
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 2.55 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- VSTM Tweets Stocktwits
Advertisement
